Lenalidomide safe as single therapy for elderly CLL patients
Tuesday, December 9, 2008 - 06:03
in Health & Medicine
The oral medication lenalidomide is safe and well-tolerated for elderly patients with chronic lymphocytic leukaemia, a group without a well-defined frontline therapy for their disease, researchers from The University of Texas M. D. Anderson Cancer Centre reported at the 50th annual meeting of the American Society of Hematology...
Read the whole article on Science Centric
More from Science Centric
Related
- Lenalidomide safe as single therapy for elderly CLL patientsMon, 8 Dec 2008, 17:45:13 EST
- Second-generation CML drugs show promise as frontline therapyMon, 8 Dec 2008, 17:45:39 EST
- New therapy prevents dangerous side effect for lymphoma patientsTue, 9 Dec 2008, 13:19:25 EST
- New prognostic model for MDS covers all phases of diseaseTue, 9 Dec 2008, 6:06:42 EST
- Intense chemotherapy wards off recurrence in half of mantle cell lymphoma patients after seven yearsTue, 9 Dec 2008, 13:19:18 EST